Pendulum Therapeutics Funding: $111M Raised, Series C (2021)
Pendulum Therapeutics is based in San Francisco. It has raised $111M in total funding. Latest round: Series C.
Pendulum Therapeutics funding overview
Pendulum Therapeutics is based in San Francisco. Pendulum Therapeutics has raised $111M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in April 2021. The round record for Pendulum Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Meritech Capital, Sequoia Capital, True Ventures, Khosla Ventures, Mayo Clinic, AME Cloud Ventures. 6 distinct backers are named across the disclosed rounds.
Frequently asked about Pendulum Therapeutics funding
How much has Pendulum Therapeutics raised?
Pendulum Therapeutics has raised $111M in total disclosed funding across the rounds on record.
Who has invested in Pendulum Therapeutics?
Meritech Capital, Sequoia Capital, True Ventures, Khosla Ventures, Mayo Clinic, AME Cloud Ventures are named among the investors backing Pendulum Therapeutics.
What was the latest Pendulum Therapeutics funding round?
The most recent disclosed round is a Series C, announced in April 2021.
Where is Pendulum Therapeutics based?
Pendulum Therapeutics is based in San Francisco.
When did Pendulum Therapeutics last raise?
The last disclosed Pendulum Therapeutics round closed in April 2021 at Series C.
Pendulum Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in San Francisco below to benchmark round size and investor mix.
